유방 생검 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 시술별, 유도 기술별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Breast Biopsy Devices Market Summary

The global breast biopsy devices market size was estimated at USD 3.52 billion in 2025 and is projected to reach USD 5.60 billion by 2033, growing at a CAGR of 6.04% from 2026 to 2033. The market is primarily driven by the rising global incidence of breast cancer and increasing demand for early and accurate diagnosis.

The expansion of national screening programs and greater awareness of routine mammography are leading to more abnormalities being detected, requiring biopsy confirmation. Technological advancements in minimally invasive and image-guided biopsy techniques are improving diagnostic precision and patient comfort.

In addition, the expansion of healthcare infrastructure and outpatient care facilities is driving higher procedural volumes worldwide. According to Breastcancer.org, in 2026, it is estimated that about 42,140 women in the U.S. will die from breast cancer, highlighting the continuing mortality burden of the disease despite advances in early detection and treatment.

The increasing global burden of breast cancer is a major driver of the breast biopsy devices industry. As the number of newly diagnosed cases continues to rise worldwide, the demand for accurate and timely diagnostic procedures has grown significantly. Breast biopsy devices play a critical role in confirming malignancy in cases with abnormal imaging findings. Consequently, higher incidence rates directly contribute to increased procedure volumes, driving sustained growth in the breast biopsy devices industry. According to Breastcancer.org, about 1 in 8 women in the U.S. (approximately 13%) will be diagnosed with invasive breast cancer during their lifetime. Each year, breast cancer represents roughly 30% of all newly diagnosed cancers among U.S. women, making it one of the most common cancers affecting women. These statistics highlight the significant impact and ongoing burden of breast cancer nationwide.

Global Breast Biopsy Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global breast biopsy devices market report based on product, procedure, guidance technology, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Biopsy Guidance Systems
• Biopsy Drivers & Handpieces
  • Vacuum-Assisted Biopsy (VAB) Drivers
  • Core Needle Biopsy (CNB) Guns
  • Automated
  • Semi-Automated
• Biopsy Tables
  • Prone Tables
  • Upright/Add-on Tables
• Biopsy Consumables
  • Needles & Probes
  • Site Markers & Clips
• By Shape/Design
• Standard Geometric Markers
  • Ring
  • Cross
  • Ribbon
  • Others
• Advanced Anchoring Markers
  • Anchor
  • Wing, "U" Shape
  • Q" Shape
• 3D / Expandable Markers
  • 3D Ribbon
  • 3D Sphere
  • 3D Mesh
• Localization Systems
  • Traditional Wires
  • Wireless Seeds-RFID/Magnetic
• Other Consumables
• Procedure Outlook (Revenue, USD Million, 2021 - 2033)
• Vacuum-Assisted Biopsy (VAB)
• Core Needle Biopsy (CNB)
• Fine Needle Aspiration Biopsy (FNAB)
• Surgical (Open) Biopsy
• Liquid Biopsy
• Guidance Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Ultrasound-Guided
• Mammography / Stereotactic-Guided
• MRI-Guided
• End Use Outlook (Revenue, USD Million; 2021 - 2033)
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialized Breast Care Centers
• Diagnostic Centers/Imaging Centers
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Product
  • 1.1.2. Procedure
  • 1.1.3. Guidance Technology
  • 1.1.4. End Use
  • 1.1.5. Regional scope
  • 1.1.6. Estimates and forecast timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Breast Biopsy Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Increasing burden of breast cancer
    • 3.2.1.2. Expansion of breast cancer screening programs
    • 3.2.1.3. Technological advancements in imaging-guided biopsy
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. High cost of advanced biopsy technologies
    • 3.2.2.2. Limited access to diagnostic facilities in low-resource settings
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Expansion of screening programs in emerging economies
    • 3.2.3.2. Growth of minimally invasive and rapid diagnostic technologies
    • 3.2.3.3. Integration with next-generation imaging and AI
    • 3.2.3.4. Expansion of outpatient and ambulatory care
    • 3.2.3.5. Rising demand for personalized and precision diagnostics
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Patient anxiety and procedure hesitation
    • 3.2.4.2. Limited skilled workforce
• 3.3. Breast Biopsy Devices Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Breast Biopsy Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Breast Biopsy Devices Market: Product Movement Analysis, 2025 & 2033 (USD Million)
• 4.3. Global Breast Biopsy Devices Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.3.1. Biopsy Guidance Systems
    • 4.3.1.1. Biopsy guidance systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.3.2. Biopsy Drivers & Handpieces
    • 4.3.2.1. Biopsy drivers & handpieces market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.2. Vacuum-assisted biopsy (VAB) drivers
      • 4.3.2.2.1. Vacuum-assisted biopsy (VAB) drivers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.3. Core needle biopsy (CNB) guns
      • 4.3.2.3.1. Core needle biopsy (CNB) guns market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.3.2. Automated
        • 4.3.2.3.2.1. Automated market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.3.3. Semi-automated
        • 4.3.2.3.3.1. Semi-automated market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.3.3. Biopsy tables
    • 4.3.3.1. Biopsy tables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.3.2. Prone tables
      • 4.3.3.2.1. Prone tables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.3.3. Upright/add-on tables
      • 4.3.3.3.1. Upright/add-on tables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.3.4. Biopsy consumables
    • 4.3.4.1. Biopsy consumables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.4.2. Needles & probes
      • 4.3.4.2.1. Needles & probes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.4.3. Site markers & clips
      • 4.3.4.3.1. Site markers & clips market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.4.3.2. By shape/design
        • 4.3.4.3.2.1. By shape/design market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.4.3.3. Standard geometric markers
        • 4.3.4.3.3.1. Standard geometric markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.3.2. Ring
          • 4.3.4.3.3.2.1. Ring market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.3.3. Cross
          • 4.3.4.3.3.3.1. Cross market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.3.4. Ribbon
          • 4.3.4.3.3.4.1. Ribbon market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.3.5. Others
          • 4.3.4.3.3.5.1. Others markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.4.3.4. Advanced anchoring markers
        • 4.3.4.3.4.1. Advanced anchoring markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.4.2. Anchor
          • 4.3.4.3.4.2.1. Anchor markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.4.3. Wing, "U" shape
          • 4.3.4.3.4.3.1. Wing, "U" shape market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.4.4. "Q" shape
          • 4.3.4.3.4.4.1. "Q" shape markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.4.3.5. 3D / expandable markers
        • 4.3.4.3.5.1. 3D / expandable markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.5.2. 3D ribbon
          • 4.3.4.3.5.2.1. 3D ribbon market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.5.3. 3D sphere
          • 4.3.4.3.5.3.1. 3D Sphere market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.5.4. 3D Mesh
          • 4.3.4.3.5.4.1. 3D Mesh market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.4.4. Localization systems
      • 4.3.4.4.1. Localization systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.4.4.2. Traditional wires
        • 4.3.4.4.2.1. Traditional wires market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.4.4.3. Wireless Seeds-RFID/magnetic
        • 4.3.4.4.3.1. Wireless seeds-RFID/magnetic market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.3.5. Other Consumables
    • 4.3.5.1. Other Consumables market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Breast Biopsy Devices Market: Procedure Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Breast Biopsy Devices Market: Procedure Movement Analysis, 2025 & 2033 (USD Million)
• 5.3. Global Breast Biopsy Devices Market Size & Trend Analysis, by Procedure, 2021 to 2033 (USD Million)
  • 5.3.1. Vacuum-Assisted Biopsy (VAB)
    • 5.3.1.1. Vacuum-assisted biopsy (VAB) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.3.2. Core Needle Biopsy (CNB)
    • 5.3.2.1. Core needle biopsy (CNB) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.3.3. Fine Needle Aspiration Biopsy (FNAB)
    • 5.3.3.1. Fine needle aspiration biopsy (FNAB) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.3.4. Surgical (Open) Biopsy
    • 5.3.4.1. Surgical (open) biopsy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.3.5. Liquid Biopsy
    • 5.3.5.1. Liquid biopsy market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Breast Biopsy Devices Market: Guidance Technology Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Breast Biopsy Devices Market: Guidance Technology Movement Analysis, 2025 & 2033 (USD Million)
• 6.3. Global Breast Biopsy Devices Market Size & Trend Analysis, by Guidance Technology, 2021 to 2033 (USD Million)
  • 6.3.1. Ultrasound-Guided
    • 6.3.1.1. Ultrasound-guided market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. Mammography / Stereotactic-Guided
    • 6.3.2.1. Mammography / stereotactic-guided market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.3. MRI-Guided
    • 6.3.3.1. MRI-guided market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Breast Biopsy Devices Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Breast Biopsy Devices Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
• 7.3. Global Breast Biopsy Devices Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
  • 7.3.1. Hospitals
    • 7.3.1.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. Ambulatory Surgical Centers (ASCs)
    • 7.3.2.1. Ambulatory surgical centers (ASCs) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Specialized Breast Care Centers
    • 7.3.3.1. Specialized breast care centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. Diagnostic Centers/Imaging Centers
    • 7.3.4.1. Diagnostic centers/imaging centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Breast Biopsy Devices Market: Regional Estimates & Trend Analysis by Product, Procedure, Guidance Technology, and End Use

• 8.1. Regional Dashboard
• 8.2. Market Size and Trend Analysis, 2021 to 2033
• 8.3. North America
  • 8.3.1. North America breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Competitive scenario
    • 8.3.2.3. Regulatory framework
    • 8.3.2.4. Reimbursement scenario
    • 8.3.2.5. U.S. breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Competitive scenario
    • 8.3.3.3. Regulatory framework
    • 8.3.3.4. Reimbursement scenario
    • 8.3.3.5. Canada breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key country dynamics
    • 8.3.4.2. Competitive scenario
    • 8.3.4.3. Regulatory framework
    • 8.3.4.4. Reimbursement scenario
    • 8.3.4.5. Mexico breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory framework
    • 8.4.2.4. Reimbursement scenario
    • 8.4.2.5. UK breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory framework
    • 8.4.3.4. Reimbursement scenario
    • 8.4.3.5. Germany breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Competitive scenario
    • 8.4.4.3. Regulatory framework
    • 8.4.4.4. Reimbursement scenario
    • 8.4.4.5. France breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Competitive scenario
    • 8.4.5.3. Regulatory framework
    • 8.4.5.4. Reimbursement scenario
    • 8.4.5.5. Italy breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Competitive scenario
    • 8.4.6.3. Regulatory framework
    • 8.4.6.4. Reimbursement scenario
    • 8.4.6.5. Spain breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Competitive scenario
    • 8.4.7.3. Regulatory framework
    • 8.4.7.4. Reimbursement scenario
    • 8.4.7.5. Sweden breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Competitive scenario
    • 8.4.8.3. Regulatory framework
    • 8.4.8.4. Reimbursement scenario
    • 8.4.8.5. Denmark breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key country dynamics
    • 8.4.9.2. Competitive scenario
    • 8.4.9.3. Regulatory framework
    • 8.4.9.4. Reimbursement scenario
    • 8.4.9.5. Norway breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Reimbursement scenario
    • 8.5.2.5. China breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. Japan
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Reimbursement scenario
    • 8.5.3.5. Japan breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory framework
    • 8.5.4.4. Reimbursement scenario
    • 8.5.4.5. India breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory framework
    • 8.5.5.4. Reimbursement scenario
    • 8.5.5.5. South Korea breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Competitive scenario
    • 8.5.6.3. Regulatory framework
    • 8.5.6.4. Reimbursement scenario
    • 8.5.6.5. Australia breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Competitive scenario
    • 8.5.7.3. Regulatory framework
    • 8.5.7.4. Reimbursement scenario
    • 8.5.7.5. Thailand breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Reimbursement scenario
    • 8.6.2.5. Brazil breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. Reimbursement scenario
    • 8.6.3.5. Argentina breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.7. Middle East and Africa
  • 8.7.1. Middle East and Africa breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Reimbursement scenario
    • 8.7.2.5. South Africa breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Reimbursement scenario
    • 8.7.3.5. Saudi Arabia breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. Reimbursement scenario
    • 8.7.4.5. UAE breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Competitive scenario
    • 8.7.5.3. Regulatory framework
    • 8.7.5.4. Reimbursement scenario
    • 8.7.5.5. Kuwait breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis by Key Market Participants
• 9.2. Company Categorization
• 9.3. Company Market Share Analysis, 2025
• 9.4. Company Heat Map Analysis
• 9.5. Strategy Mapping
  • 9.5.1. Expansion
  • 9.5.2. Mergers & Acquisition
  • 9.5.3. Partnerships & Collaborations
  • 9.5.4. New Product Launches
  • 9.5.5. Research And Development
  • 9.5.6. Company Profiles
  • 9.5.7. Hologic, Inc.
    • 9.5.7.1. Company overview
    • 9.5.7.2. Financial performance
    • 9.5.7.3. Product Benchmarking
    • 9.5.7.4. Strategic initiatives
  • 9.5.8. Mammotome (Danaher)
    • 9.5.8.1. Company overview
    • 9.5.8.2. Financial performance
    • 9.5.8.3. Product Benchmarking
    • 9.5.8.4. Strategic initiatives
  • 9.5.9. BD
    • 9.5.9.1. Company overview
    • 9.5.9.2. Financial performance
    • 9.5.9.3. Product Benchmarking
    • 9.5.9.4. Strategic initiatives
  • 9.5.10. Argon Medical
    • 9.5.10.1. Company overview
    • 9.5.10.2. Financial performance
    • 9.5.10.3. Product Benchmarking
    • 9.5.10.4. Strategic initiatives
  • 9.5.11. Merit Medical Systems
    • 9.5.11.1. Company overview
    • 9.5.11.2. Financial performance
    • 9.5.11.3. Product Benchmarking
    • 9.5.11.4. Strategic initiatives
  • 9.5.12. GE HealthCare
    • 9.5.12.1. Company overview
    • 9.5.12.2. Financial performance
    • 9.5.12.3. Product Benchmarking
    • 9.5.12.4. Strategic initiatives
  • 9.5.13. Cook Medical
    • 9.5.13.1. Company overview
    • 9.5.13.2. Financial performance
    • 9.5.13.3. Product Benchmarking
    • 9.5.13.4. Strategic initiatives
  • 9.5.14. MOLLI Surgical (Stryker)
    • 9.5.14.1. Company overview
    • 9.5.14.2. Financial performance
    • 9.5.14.3. Product Benchmarking
    • 9.5.14.4. Strategic initiatives
  • 9.5.15. Planmed Oy
    • 9.5.15.1. Company overview
    • 9.5.15.2. Financial performance
    • 9.5.15.3. Product Benchmarking
    • 9.5.15.4. Strategic initiatives
  • 9.5.16. Metaltronica Spa
    • 9.5.16.1. Company overview
    • 9.5.16.2. Financial performance
    • 9.5.16.3. Product Benchmarking
    • 9.5.16.4. Strategic initiatives
  • 9.5.17. Trivitron Healthcare
    • 9.5.17.1. Company overview
    • 9.5.17.2. Financial performance
    • 9.5.17.3. Product Benchmarking
    • 9.5.17.4. Strategic initiatives
  • 9.5.18. Siemens Healthineers
    • 9.5.18.1. Company overview
    • 9.5.18.2. Financial performance
    • 9.5.18.3. Product Benchmarking
    • 9.5.18.4. Strategic initiatives
  • 9.5.19. Fujifilm Healthcare
    • 9.5.19.1. Company overview
    • 9.5.19.2. Financial performance
    • 9.5.19.3. Product Benchmarking
    • 9.5.19.4. Strategic initiatives
  • 9.5.20. INRAD
    • 9.5.20.1. Company overview
    • 9.5.20.2. Financial performance
    • 9.5.20.3. Product Benchmarking
    • 9.5.20.4. Strategic initiatives
  • 9.5.21. SteryLab
    • 9.5.21.1. Company overview
    • 9.5.21.2. Financial performance
    • 9.5.21.3. Product Benchmarking
    • 9.5.21.4. Strategic initiatives
  • 9.5.22. Resitu Medical
    • 9.5.22.1. Company overview
    • 9.5.22.2. Financial performance
    • 9.5.22.3. Product Benchmarking
    • 9.5.22.4. Strategic initiatives
  • 9.5.23. TransMed7, LLC.
    • 9.5.23.1. Company overview
    • 9.5.23.2. Financial performance
    • 9.5.23.3. Product Benchmarking
    • 9.5.23.4. Strategic initiatives